NPPA computed the Retail Price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Eris Lifesciences Ltd. (Marketer)

Mar 07, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 04, 2025, issued the Computation of Retail Price of Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Eris Lifesciences Ltd. (Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from July, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg (As Extended Release) for M/s Pure and Cure Healthcare Pvt. Ltd. (Manufacturer) and M/s Eris Lifesciences Ltd. (Marketer)

• The Total MAT is 33,45,97,025


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT